Our Mission and Values
Board
Leadership Team
Scientific Advisory
Corporate Governance
Intellectual Property
Pipeline
CVac™
Monoclonal Antibody
Vaccines Program
R&D
Ovarian Cancer
About CVac™
Treatment
Clinical Trials
Clinical Trials
CVac™
CAN-003
CANVAS
FAQ
Useful Links
Contact Us
Analyst Reports
Presentations
Annual Reports
Mailing List
Movie about CVac™
Investor Updates
Announcements
Announcements
Archive
Announcements
03 February 2012
First Patient Enrolled for CANVAS
>>
17 January 2012
Japanese Patent Granted for Cripto-1 Antibody
>>
25 October 2011
Manufacturing Authorisation Granted in Germany
>>
Privacy Policy
© 2012 PRIMA BIOMED LTD. All Rights Reserved.
Home
Site Map
Contact Us
Search